Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART)
about
Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.Improving Adherence to Antiretroviral Therapy With Triggered Real-time Text Message Reminders: The China Adherence Through Technology StudyCan Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa.Marijuana use and viral suppression in persons receiving medical care for HIV-infection.Prevalence and clinical impact of recreational drug consumption in people living with HIV on treatment: a cross-sectional study.Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: An interrupted time series analysis.Trajectories of Marijuana Use among HIV-seropositive and HIV-seronegative MSM in the Multicenter AIDS Cohort Study (MACS), 1984-2013.Side effects, adherence self-efficacy, and adherence to antiretroviral treatment: a mediation analysis in a Chinese sample.Long-Acting Antiretrovirals: Where Are We now?Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy.Adherence to combination antiretroviral treatment and clinical outcomes in a Medicaid sample of older HIV-infected adults.Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.Barriers and facilitators of antiretroviral therapy adherence in rural Eastern province, Zambia: the role of household economic status.The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States.Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL.Predictors of Self-Reported Adherence to Antiretroviral Medication in a Multisite Study of Ethnic and Racial Minority HIV-Positive Youth.Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment-Clinical Points of View and Practical Considerations.Patterns of Substance Use and Arrest Histories Among Hospitalized HIV Drug Users: A Latent Class Analysis.Psychiatric Disorders, Antiretroviral Medication Adherence, and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults.Higher Art Adherence is Associated with Lower Systemic Inflammation in Treatment-Naïve Ugandans Who Achieve Virologic Suppression.Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring.Do Persons Living with HIV Continue to Fill Prescriptions for Antiretroviral Drugs during a Gap in Care? Analysis of a Large Commercial Claims Database.A competitive lateral flow assay for the detection of tenofovir.A Novel Integrated Cognitive-Behavioral Therapy for Anxiety and Medication Adherence Among Persons Living With HIV/AIDS.Prevalence and Associations of Illicit Drug and Polydrug Use in People Living with HIV in Vienna.
P2860
Q35847912-7945280C-FEB0-4567-821A-F7DC7625B5CAQ36004031-9FEB8961-2244-430D-B434-A7F245FD111CQ37348464-42D3566C-F859-46FD-BD3F-CC4D2E47294CQ37580761-1487F9E3-1664-488E-AF9D-169E67139C47Q37598206-F8C36D81-574D-4C20-B44E-699F963F0999Q38814243-5E64C89E-44FC-4CDC-A97D-C53280A74501Q38858380-49A10FBA-4C40-43A8-971A-6574378D3D74Q38890706-5B980B21-FA65-4765-A259-867AADB1CE5CQ38902077-2144510C-12A8-40D7-8AEA-2C00B99256DBQ39060951-3D239B43-472C-472F-84E6-E672F40673F6Q39148090-075CB450-9282-4C8D-8FC5-495C060CCB90Q39359637-7B008AD5-A6DB-4D4B-AE2E-1685305336D5Q40162440-2F7FE7C2-0892-4D6F-8719-4E3911AA55F9Q40179664-7C17E70C-7044-4B7A-B166-0A2A19946125Q40212933-1EB3BE5E-B74B-4ECA-941C-31B3C6608E9FQ40395888-43C5BB2B-D060-486A-B46C-28F072BB4EEDQ47104527-637631C4-3899-45C2-8EFF-E37F08A7EF30Q47203184-3E1F10D9-C8C3-4FDC-958F-73F0E2CDF663Q47331437-1A9D0987-E86B-4A87-99B6-E3D4D52BEB8BQ47551904-854B932A-6111-4D64-B09E-5963AF4942C1Q49587788-D935BC48-7CFF-4651-8A94-F1DF2857B617Q50129820-882B7F12-A860-4033-BADA-215E34A839B0Q53702307-B135F3E4-00C0-4FE6-8FC4-6C468864DDEAQ54214608-61F44555-747A-4D85-B061-422370C1A393Q54974866-7BB9D4FB-99A3-4619-903D-ECF5B72590E0
P2860
Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART)
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Level of adherence and HIV RNA ...... antiretroviral therapy (HAART)
@ast
Level of adherence and HIV RNA ...... antiretroviral therapy (HAART)
@en
type
label
Level of adherence and HIV RNA ...... antiretroviral therapy (HAART)
@ast
Level of adherence and HIV RNA ...... antiretroviral therapy (HAART)
@en
prefLabel
Level of adherence and HIV RNA ...... antiretroviral therapy (HAART)
@ast
Level of adherence and HIV RNA ...... antiretroviral therapy (HAART)
@en
P2093
P2860
P1433
P1476
Level of adherence and HIV RNA ...... antiretroviral therapy (HAART)
@en
P2093
Bernard J C Macatangay
Gregory D Kirk
Lisa P Jacobson
Roger Detels
Shilpa Viswanathan
Shruti H Mehta
P2860
P2888
P304
P356
10.1007/S10461-014-0927-4
P577
2015-04-01T00:00:00Z